A Novel Mechanism Of Berberine Targeting Eif2Ak2 Dimerization Attenuates Methylglyoxal-Induced Endothelial Senescence And Apoptosis
As we age, our blood vessels also undergo changes, a process known as vascular aging. A key player in this process is a substance called methylglyoxal (MGO), which accumulates in the body over time and contributes to the damage and dysfunction of the cells lining our blood vessels, called endothelial cells. This damage can lead to serious health issues.
Scientists have identified a protein, EIF2AK2 (also known as PKR), that plays a significant role in promoting the aging and death of these crucial endothelial cells. When MGO is present, it activates EIF2AK2, triggering a cascade of events that ultimately harms the cells.
However, a natural compound called berberine, found in plants like barberry, offers a promising solution. Research shows that berberine can protect these endothelial cells by interfering with EIF2AK2. Specifically, it prevents EIF2AK2 molecules from joining together, a process called dimerization. By blocking this dimerization, berberine stops EIF2AK2 from becoming active and initiating the harmful cellular processes that lead to cell aging and death. It also influences another protein, eIF2α, preventing a chemical modification (phosphorylation) that would otherwise halt the cell’s ability to produce new proteins, essentially shutting down its “assembly line” and leading to its demise.
This discovery sheds light on a novel way to combat vascular aging and suggests that berberine, by targeting EIF2AK2, could be a valuable therapeutic agent for preventing and treating various vascular diseases.
Source: link to paper